InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company also develops INF904, an oral, small molecule drug candidate for the undisclosed chronic inflammatory and autoimmune diseases; and IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of InflaRx N.V..
InflaRx N.V. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of InflaRx N.V. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of InflaRx N.V. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of InflaRx N.V. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of InflaRx N.V. and all latest updates of the company are provided.
The 2025 version of InflaRx N.V. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 InflaRx N.V.- Key Facts
2.2 InflaRx N.V.- Geographic Locations
2.3 InflaRx N.V.- Subsidiaries and Affiliates
2.4 InflaRx N.V.- Business Divisions
2.5 InflaRx N.V.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. InflaRx N.V. Strategic Analysis Review
3.1 InflaRx N.V.- Key Strategies
3.2 InflaRx N.V.- Company Outlook Statement
3.3 InflaRx N.V.- SWOT Analysis
3.3.1 InflaRx N.V.- Key Strengths
3.3.2 InflaRx N.V.- Key Weaknesses
3.3.3 InflaRx N.V.- Potential Opportunities
3.3.4 InflaRx N.V.- Potential Threats
3.4 InflaRx N.V.- Key Competitors
4. Business Description of the Company
4.1 InflaRx N.V.- Business Overview
4.2 InflaRx N.V.- Operations by Segment
5 Products and Services Details
5.1 InflaRx N.V.- Key Products
5.2 InflaRx N.V.- Key Service Areas
5.3 InflaRx N.V.- Key Brands
6 Company Developments
6.1 InflaRx N.V.- Company History
6.2 InflaRx N.V.- Latest Developments
7 Financial Analysis
7.1 InflaRx N.V.- Income Statements
7.2 InflaRx N.V.- Balance Sheet
7.3 InflaRx N.V.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 InflaRx N.V.- Direct Competitors
8.2 InflaRx N.V.- Competitor Financial Ratios comparison
8.3 InflaRx N.V.- Competitor Stock Charts Comparison
8.4 InflaRx N.V.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
